ArticleBiochimica et biophysica acta2010

A monovalent agonist of TrkA tyrosine kinase receptors can be converted into a bivalent antagonist.

Fouad Brahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.